|
Sorted by: Date | Top Results
|
|
Author |
|
Date |
| |
| |
| 1. |
Re: A $3B market is who cares!!! Faster onset is a very big deal! 
Viagra and Levitra are in very large $3+B markets and
with very consistent product switching. This means
there is very little loyalty between these two pr
oducts...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
27-Oct-09 05:29 pm |
| |
| 2. |
Re: Ostriches lose money
Mwy-or-the.... I agree 100% - in my understanding this
adds to the PAS and would make it stronger. Why would
any doctor not want that? Apparently these...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
15-Oct-09 11:47 am |
| |
| 3. |
Risk vs Reward - it where winners are produced.
Not sure on your perspective Bragacbw but is sounds
negative. From my understanding this study is an excellent
example of how Aspen's new APPYSCORE blood test
can help doctors throughout...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
9-Oct-09 04:48 pm |
| |
| 4. |
Re: Avanafil - is not chopped liver either!
Agree 100% - data just has to be consistent and its
a win - how big a win? I think a significant stock
price driver that builds on the Qnexa probability
of success due to the achievements...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
7-Oct-09 04:53 pm |
| |
| 5. |
Re: Avanafil - is not chopped liver either!
Late October release of Avanafil would be nice! Imagine
if you have either Viagra or Cialas and your massive
market share is starting to dwindle (current users
starting to wain) etc. This new...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
7-Oct-09 04:17 pm |
| |
| 6. |
Re: Nothing to worry, keep holding
I agree with you and clearly the street agrees with
the plan here. Nice volume so far today, well above
the fund raise level. A very good sign for their future
plans and level of confidence. Only time will tell
but I like the way...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
7-Oct-09 11:57 am |
| |
| 7. |
They have to have good reasons to do this now.
I know Falkner and his associates are not amateurs
at this process. They must have very good reasons
for doing this now. Even though they don't need
to do it right now. They obviously...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
7-Oct-09 09:47 am |
| |
| 8. |
Re: More Starting to Warm to Falkner&&39;s Milestones + 12 Hospital Study that Started 4 Months Ago
Yes - as time goes on that Animal Business is going
to get closer to market and what I believe is a very
attractive $10+ million royalty stream with Novartis
that could start...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
6-Oct-09 02:29 pm |
| |
| 9. |
More Starting to Warm to Falkner&&39;s Milestones + 12 Hospital Study that Started 4 Months Ago
Imagine the power this stock is going to have if they
can answer the FDA questions with solid data from
their current 12 Hospital Study + report solid study
results + get their FDA 510k...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
6-Oct-09 01:03 pm |
| |
| 10. |
We Don&&39;t Know - That doesn&&39;t mean its all crooked.
I am out of SQNM for now. I have watched what I believe
to be well informed investors lose their shirt on
this stock - yet, as a high science person who believes
in...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Sequenom Inc. (SQNM)
|
|
mcmoney60 |
|
6-Oct-09 10:55 am |
| |
| 11. |
After hours number is so bogus - 100 shares traded at $1.93
Who is the fool trying to do that? Imagine just a tiny
set of 100 shares can show as being down 3.5% after
hours - what a crock! This stock is going to rock
- if the 12...
Business & Finance > Investments > Stocks (A to Z) > Stocks A >
AspenBio Pharma Inc. (APPY)
|
|
mcmoney60 |
|
5-Oct-09 05:04 pm |
| |
| 12. |
Avanafil - is not chopped liver either!
Faster acting and safer. In a $3B market! That's
an impressive second act if you ask me. FDA site says
final patent enrollment was Aug 2009 - anyone know
(approximately of course) when this...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
5-Oct-09 04:54 pm |
| |
| 13. |
Re: Update
Simple answer! Getting an FDA letter (response to marketing
description / words or inference) is so common in
the industry that, other than a niave investor excuse,
it laughable. All of the good pharma...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
2-Oct-09 03:23 pm |
| |
| 14. |
Re: Who cares - where oh where is rbpass????
I don't know where he is but please explain to
me why Heska's share price is increasing? Based
on what growth,revenue,profits,new products? What
about the loss of 18% of...
Business & Finance > Investments > Stocks (A to Z) > Stocks H >
Heska Corporation (HSKA)
|
|
mcmoney60 |
|
1-Oct-09 11:17 am |
| |
| 15. |
Re: FDA warning letter to VVUS CEO
This is so "Amateur" - especially a marketing
warning letter from FDA - show me a company that has
a lot of these and I will show you a company that
is maximizing...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
28-Sep-09 11:19 am |
| |
| 16. |
Re: Bashers playing the Fen-phen scare tactic...
Obviously safety is critical and negative side-effect
diligence in this case is warranted. However, the
whole purpose of VVUS's efforts here have not
just been focused on...
Business & Finance > Investments > Stocks (A to Z) > Stocks V >
VIVUS, Inc. (VVUS)
|
|
mcmoney60 |
|
28-Sep-09 11:05 am |
| |
| 17. |
Re: HPV revenue potential
You don't know your negative facts pal - anyone
who tells you the revenue and value of the $1.4B Digene
sales was due to tests other than HPV is simply not
true. You can stay...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Sequenom Inc. (SQNM)
|
|
mcmoney60 |
|
24-Sep-09 07:26 pm |
| |
| 18. |
Re: HPV
Keep in mind that the annual HPV testing market is
over 20 times what the HPV vaccination market is.
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Sequenom Inc. (SQNM)
|
|
mcmoney60 |
|
24-Sep-09 01:07 pm |
| |
| 19. |
Re: HPV
The facts don't support your note. Check out Qiagen's
cc or recent quarterly report if you don't think
HPV test sales are valuable. Merck is trying to generate
Guardasil sales in poor...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Sequenom Inc. (SQNM)
|
|
mcmoney60 |
|
24-Sep-09 01:05 pm |
| |
| 20. |
Re: HPV revenue potential
Digene (the leading HPV testing platform) - was purchased
by Qiagen for $1.4B in 07. HPV was their only asset.
The value of HPV testing today is even...
Business & Finance > Investments > Stocks (A to Z) > Stocks S >
Sequenom Inc. (SQNM)
|
|
mcmoney60 |
|
24-Sep-09 09:38 am |
| |